ACON
AclarionยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ACON Profile
Aclarion, Inc.
A healthcare technology company that develops software application for magnetic resonance spectroscopy (MRS) in the US
Life Science Tools and Services
--
04/22/2022
NASDAQ Stock Exchange
6
12-31
Common stock
8181 Arista Place, Suite 100, Broomfield, Colorado 80021
--
Aclarion, Inc., was incorporated in Delaware in February 2015. The company is a healthcare technology company that utilizes magnetic resonance spectroscopy, and proprietary biomarkers to optimize clinical treatments. Aclarion's technology addresses the US $134.5B lower back and neck pain market, which is now the most expensive healthcare disease in the US, according to a 2020 JAMA article. The company is currently utilizing artificial intelligence to assist quality control processes that flag spectral data that indicate poor MRS research. The use of AI in this application is early in its development cycle and is expected to evolve with further research and development.
